02.06.2010 • NewsBASFportfolioMergers & Acquisitions (M&A)

BASF Near Agreeing Takeover of Cognis

BASF has in principle agreed with the private equity owners of Cognis on a takeover of the German maker of additives, a newspaper reported on Wednesday.

BASF, the world's largest chemicals maker, and Cognis's owners Permira and Goldman Sachs Capital Partners have come to terms on the price and on the main conditions of the deal, Financial Times Deutschland (FTD) said, citing people familiar with the talks. An official announcement should, however, not be expected before mid-June, because BASF plans to carry out final checks as part of a "confirmatory due diligence", the paper added.

FTD said it could not ascertain the agreed acquisition price for the maker of chemicals for cosmetics and detergents.

Cognis's CFO Marco Panichi, citing prevailing core earnings multiples in the industry, indicated last month that a fair value for Cognis could be about €3.4 billion, according to Reuters calculations. Cognis's private equity owners relaunched their campaign to sell the company outright even as it prepared to go public.

One person familiar with the matter said this month that offers had been more than €3 billion but less than €3.5 billion, including assumed debt. Sources told Reuters earlier this year that U.S. specialty chemicals maker Lubrizol and at least one other company had also been interested in Cognis but sources have recently said BASF had become a clear frontrunner in the auction.

Company

Logo:

BASF SE

Carl-Bosch-Straße 38
67056 Ludwigshafen
Germany

Company contact







Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.